← Eichor
Study identifier: NCT07227246 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

Condition: Intracerebral Hemorrhage  ·  Sponsor: Joseph Broderick, MD

PhasePhase 3
Planned participants350
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 90 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy. FASTEST Part 2 is an extension of the FASTEST Trial where the subgroups include those treated within 2 hours with a positive spot sign on a baseline CT angiogram or patients treated within 90 minutes of stroke onset, with or without a positive spot sign.

This description comes directly from the study's public registry record.

Talk to the study team

Joseph P Broderick, MD  ·  15139195404  ·  broderjp@ucmail.uc.edu

James Grotta, MD  ·  (281) 387-2329  ·  james.c.grotta@uth.tmc.edu

Always discuss trial participation with your own doctor first.

Locations (89)

University of Alabama HospitalBirmingham, Alabama, United StatesRecruiting
Kaiser Permanente Baldwin Park Medical CenterBaldwin Park, California, United StatesRecruiting
Mills Peninsula Medical CenterBurlingame, California, United StatesRecruiting
Kaiser Permanente Downey Medical CenterDowney, California, United StatesRecruiting
Kaiser Permanente Fontana Medical CenterFontana, California, United StatesRecruiting
Kaiser Permanente South Bay Medical CenterHarbor City, California, United StatesRecruiting
UCSD Health La JollaLa Jolla, California, United StatesRecruiting
Kaiser Permanente Los Angeles Medical CenterLos Angeles, California, United StatesRecruiting
Kaiser Permanente West Los Angeles Medical CenterLos Angeles, California, United StatesRecruiting
Ronald Reagan UCLA Medical CenterLos Angeles, California, United StatesRecruiting
UC Irvine Medical Center,Orange, California, United StatesRecruiting
Kaiser Permanente Riverside Medical CenterRiverside, California, United StatesRecruiting

+ 77 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07227246